within Pharmacolibrary.Drugs.ATC.R;

model R05CB09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 0.0008333333333333334,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R05CB09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Letosteine is a mucolytic agent structurally related to acetylcysteine. It was developed and researched for the treatment of respiratory conditions characterized by thick mucus, such as chronic bronchitis and COPD. However, letosteine is not widely approved or in clinical use today, and it has lacked further development or broad therapeutic approval.</p><h4>Pharmacokinetics</h4><p>No human pharmacokinetic data are available in the literature for letosteine. The following parameters are estimated based on related mucolytic agents such as N-acetylcysteine, as well as standard pharmacokinetic assumptions for oral administration in adults.</p><h4>References</h4><ol><li><p>Donath, A, et al., &amp; Wermeille, M (1991). Pharmacokinetic study of 14C-letosteine in man after oral intake and steady-state. <i>European journal of drug metabolism and pharmacokinetics</i> Spec No 3 243–249. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1820888/&quot;>https://pubmed.ncbi.nlm.nih.gov/1820888</a></p></li><li><p>Gachon, F, et al., &amp; Gaillard, G (1988). Disposition and metabolism of letosteine in rats. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 16(6) 853–857. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2907465/&quot;>https://pubmed.ncbi.nlm.nih.gov/2907465</a></p></li><li><p>Liu, X, et al., &amp; Chen, H (2011). Development of a novel LC-MS/MS method for the determination of letosteine in human plasma and its application on pharmacokinetic studies. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 879(25) 2554–2560. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2011.07.011&quot;>10.1016/j.jchromb.2011.07.011</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21840272/&quot;>https://pubmed.ncbi.nlm.nih.gov/21840272</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R05CB09;
